Inhaler recognition as a marker for adherence in pediatric patients with asthma [0.03%]
吸入器识别作为哮喘患儿依从性的标志
Jenny Huang,Mansi Kothari,Rahul Revan et al.
Jenny Huang et al.
Background: Poor adherence to daily asthma controller medications contributes to increased emergency department (ED) visits and hospitalizations in children. A simple bedside tool to assess adherence is needed in clinical settings. Objectiv...
Follow-up after discontinuation of omalizumab in patients with moderate-to-severe asthma: A systematic review [0.03%]
奥马珠单抗在中重度哮喘患者中的停药后随访研究系统评价
Qiu-Li Yan,Li-Yuan Zhang,Wen-Si Niu et al.
Qiu-Li Yan et al.
Background: Omalizumab is a well-established add-on therapy for patients with moderate-to-severe asthma. However, there is limited systematic evidence on the long-term outcomes after discontinuation of this treatment. Objective: To address ...
Clinical characteristics, type 2 comorbidities, and treatment responses in pediatric and adult chronic spontaneous urticaria: A multicenter retrospective cohort study [0.03%]
一项多中心回顾性队列研究：成人和儿童慢性自发性荨麻疹的临床特点、共病及治疗反应
Kathryn Smiley,Lauren Galli,Amanda Grippen Goddard et al.
Kathryn Smiley et al.
Background: Chronic spontaneous urticaria (CSU) presents with unpredictable, often debilitating symptoms, yet detailed clinical characterization, particularly in pediatric populations, remains limited. Improved understanding of clinical pro...
Observational Study
Allergy and asthma proceedings. 2026 May 1;47(3):190-195. DOI:10.2500/aap.2026.47.260012 2026
Clinical outcomes and risk factors associated with breakthrough reactions in chemotherapy desensitization [0.03%]
突破性反应的临床结果及化疗脱敏的风险因素
Hazal Kayikci,Ebru Damadoglu,Melek Cihanbeylerden et al.
Hazal Kayikci et al.
Background: Rapid drug desensitization (RDD) is a safe and effective option for patients who are hypersensitive when no alternatives are available; however, breakthrough reactions (BTR) may still occur. Objective: This study aimed to evalua...
Time for action: How to combat myths and misinformation on social media [0.03%]
行动起来：如何打击社交媒体上的谣言与错误信息
Shane Stone,Maria P Henao,Taha Al-Shaikhly
Shane Stone
Breathing through the night: A meta-analysis of childhood asthma and obstructive sleep apnea in sleep-disordered contexts [0.03%]
睡眠障碍环境下的儿童哮喘与阻塞性睡眠呼吸暂停的meta分析研究
Kaiwen Zheng,Yuling Zhao,Jiayi Li et al.
Kaiwen Zheng et al.
Background: The study was to systematically evaluate the correlation between childhood asthma and obstructive sleep apnea (OSA). Methods: Several medical literature data bases were searched for studies published up to March 2025, by using t...
Recurrent full-body rash following chemotherapy initiation in a multiple myeloma patient [0.03%]
化疗启动后多发性骨髓瘤患者反复出现全身皮疹
Kermit Zhang,Hannah Wangberg
Kermit Zhang
Severe cutaneous adverse reactions are a spectrum of life-threatening immune mediated adverse drug reactions characterized by extensive skin involvement with the potential for organ injury. It is composed of four main entities: drug reactio...
Comorbidity burden in patients with anaphylaxis: A 25-year nationwide population-based matched case-control study [0.03%]
我国25年全国范围基于人群的配对病例对照研究中过敏性休克患者的共病负担
Eli Magen,Israel Magen,Eugene Merzon et al.
Eli Magen et al.
Background: Anaphylaxis is a severe systemic hypersensitivity reaction that occurs in diverse clinical contexts. Its broader comorbidity profile in population-based settings has not been well characterized. Objective: The objective was to e...
Should we follow the penicillin allergy label trail in approaching patients with a sulfonamide allergy label? [0.03%]
我们是否应该借鉴青霉素过敏的处理方式来对待标注有磺胺类药物过敏的患者？
Samantha R Horn,Gisoo Ghaffari,Taha Al-Shaikhly
Samantha R Horn
Background: A penicillin allergy label increases the risk of hospitalization, length of hospital stays, and even mortality rate. This recognition has led to recommendations for proactive evaluation of penicillin allergy and de-labeling effo...